MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
$26,806
EPS
$0.01
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
Total revenue
0
General and administrative
1,443,827
Research and development
2,729,891
Collaboration credits
1,658,248
In-process r&d impairment
0
Change in fair value of contingent consideration
-1,721,033
Total operating expenses
794,437
Operating (loss) income
-794,437
Interest income, net
201,822
Other expense, net
-23,708
Total other income, net
178,114
(loss) income before income tax benefit
-616,323
Income tax benefit
-643,129
Net (loss) income
26,806
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
26,806
Net (loss) income attributable to common shareholders
26,806
Net (loss) income per common share - basic (in usd per share)
0.01
Net (loss) income per common share - diluted (in usd per share)
0.01
Weighted average shares outstanding - basic (in shares)
4,289,853
Weighted average shares outstanding - diluted (in shares)
4,361,740
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Income tax benefit-$643,129 Interest income, net$201,822 Net (loss) income$26,806 (loss) income beforeincome tax benefit-$616,323 Total other income,net$178,114 Other expense, net-$23,708 Net Income Loss FromContinuing Operations...$26,806 Operating (loss) income-$794,437 Net (loss) incomeattributable to common...$26,806 Total operatingexpenses$794,437 Change in fair value ofcontingent consideration-$1,721,033 Collaboration credits$1,658,248 Research and development$2,729,891 General andadministrative$1,443,827

KIORA PHARMACEUTICALS INC (KPRX)

KIORA PHARMACEUTICALS INC (KPRX)